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Summary
Cytokinesis bridge instability leads to binucleated cells that
can promote tumorigenesis in vivo [1]. Membrane trafficking
is crucial for animal cell cytokinesis [2–8], and several endo-
cytic pathways regulated by distinct GTPases (Rab11,
Rab21, Rab35, ARF6, RalA/B) [9–16] contribute to the post-
furrowing steps of cytokinesis. However, little is known
about how these pathways are coordinated for successful
cytokinesis. The Rab35 GTPase controls a fast endocytic
recycling pathway and must be activated for SEPTIN cyto-
skeleton localization at the intercellular bridge, and thus
for completion of cytokinesis [12]. Here, we report that the
ARF6 GTPase [17, 18] negatively regulates Rab35 activation
and hence the Rab35 pathway. Human cells expressing
a constitutively activated, GTP-bound ARF6 mutant display
identical endocytic recycling and cytokinesis defects as
those observed upon overexpression of the inactivated,
GDP-bound Rab35 mutant. As a molecular mechanism, we
identified the Rab35 GAP EPI64B as an effector of ARF6 in
negatively regulating Rab35 activation. Unexpectedly, this
regulation takes place at clathrin-coated pits, and activated
ARF6 reduces Rab35 loading into the endocytic pathway.
Thus, an effector of an ARF protein is a GAP for a down-
stream Rab protein, and we propose that this hierarchical
ARF/Rab GTPase cascade controls the proper activation of
a common endocytic pathway essential for cytokinesis.Results and Discussion
ARF6 and Rab35 GTPases Act Antagonistically
in Endocytic Recycling
Small GTPases of the Rab and ARF families are well-estab-
lished regulators of membrane traffic in eukaryotic cells and
are attractive candidates for connecting and coordinating
the different endocytic pathways essential for late cytokinesis
steps [17–20]. Indeed, (1) they cycle between GDP (inactive)
states and GTP (active) states; (2) conversion between states
is precisely regulated by interactions with specific activating
GEFs (guanine nucleotide exchange factors) and deactivating4These authors contributed equally to this work
*Correspondence: arnaud.echard@pasteur.frGAPs (GTPase-activating proteins); and (3) GTP-bound
conformers interact with effector proteins that can be shared
between connected pathways. We previously reported that
human HeLa cells overexpressing the Rab35 S22N mutant
(dominant-negative, GDP-bound form of Rab35) are impaired
in fast endocytic recycling and accumulate characteristic
intracellular vacuoles positive for the PI(4,5)P2 lipid and for
F-actin in 18% of the cells ([12]; see also Figure S1A available
online). Overexpression of aGTPase-defectivemutant of ARF6
(ARF6Q67L, GTP-bound) also led to accumulation of PI(4,5)P2
and F-actin-positive vacuoles in 20% of the transfected cells
(Figure S1A), as already described [21]. This suggested that
Rab35-GDP and ARF6-GTP perturbed endocytic recycling
in a similar manner, and we hypothesized that Rab35 and
ARF6 may regulate the same transport pathway. Confirming
this hypothesis, we found that the major histocompatibility
complex class I (MHC-I), which is a reported cargo for the
ARF6 pathway [22], strongly accumulated on the intracellular
vacuoles induced by both ARF6 Q67L and Rab35 S22N (Fig-
ure 1A). In addition, the transferrin receptor (TfR), which was
known to be enriched on those vacuoles in Rab35 S22N-
expressing cells [12], also accumulated on the vacuoles
induced by ARF6 Q67L overexpression (Figure 1A). Impor-
tantly, fast endocytic recycling of internalized transferrin was
strongly reduced both in Rab35 S22N-expressing cells and
in ARF6 Q67L-expressing cells (Figure 1B). These vacuoles
were not positive for other endocytic markers such as Rab5,
EEA1, Rab4, or Rab11 (Figure S1B), indicating that there was
not a general or unspecific mixing of all endocytic pathways
in these cells. Finally, the cytoskeletal element SEPTIN2, which
is known to be associated with PI(4,5)P2 and F-actin, was
strongly reduced at the cell cortex and accumulated on the
intracellular vacuoles, both in Rab35 S22N [12] and in ARF6
Q67L-expressing cells (Figure 1A). Of note, SEPTIN2 localiza-
tion on vacuoles was not dependent on F-actin (Figure S1C).
Taken together, these results indicate that overactivation of
ARF6 and inactivation of Rab35 lead to identical endocytic
recycling defects. It also suggests that ARF6 and Rab35
GTPases act antagonistically in a common transport pathway.
ARF6 Acts Upstream of Rab35 and Antagonizes Rab35
Activation in Endocytosis and in Postfurrowing Steps
of Cytokinesis
We previously reported that endocytic recycling defects in
Rab35 S22N-expressing cells were associated with cytoki-
nesis failures characterized by delocalization of SEPTIN2 to
intracellular vacuoles, poor SEPTIN2 enrichment at the inter-
cellular bridge, and thus bridge instability [12]. ARF6 Q67L-
expressing cells are known to accumulate binucleated cells,
but it is not known at which exact step and for whichmolecular
reason cytokinesis fails [14]. Time-lapse microscopy revealed
that cells expressing either Rab35 S22N or ARF6 Q67L
mutants enteredmitosis normally but failed in cytokinesis after
furrow ingression in 20% (n = 158) and 18% (n = 165) of the
cells, respectively, as compared to 0.7% (n = 269) in control
cells (Figure S2A). Regression of the intercellular bridge was
observed 1–5 hr after its formation in both Rab35 S22N- and
ARF6 Q67L-expressing cells, leading to binucleated cells. To
Figure 1. ARF6 and Rab35 Act Antagonistically in Endocytic Recycling
(A) HeLa cells expressing either the GTPase-deficient, active ARF6 Q67L mutant or the dominant-negative, inactive Rab35 S22N mutant were stained for
the indicated proteins (green). Blue indicates DAPI staining. Insets show higher magnifications (dashed lines) of intracellular regions (upper left insets)
or cortical regions (lower right insets). Scale bar represents 20 mm.
(B) HeLa cells expressing the ARF6 Q67L mutant or the Rab35 S22N mutant were loaded with fluorescently labeled transferrin by continuous uptake at
37C for 30 min. Fast TfR recycling to the cell surface was measured by quantification of intracellular, labeled transferrin that remained after a 5 min chase
at 37C into a medium containing unlabeled transferrin. The FACS results are expressed as the intracellular fraction of loaded transferrin that was released
from cells in each condition (mean6 SEM for four independent experiments, 2,000–3,000 cells analyzed per experiment). **p < 2.53 1022 (Student’s t test).
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bility in ARF6 Q67L-expressing cells, we examined whether
SEPTIN2 enrichment, which is required for bridge stability
[23], was impaired in dividing cells, as we reported for Rab35
S22N-expressing cells [12]. In ARF6 Q67L-expressing cells,
SEPTIN2 was strongly delocalized from ingressing furrows
(data not shown) and from the cell cortex of early bridges to
intracellular vacuoles (Figure 2A), which accounts at least in
part for the observed cytokinesis defects. We conclude that
overactivation of the ARF6 GTPase or inactivation of the
Rab35 GTPase leads to similar cytokinesis defects character-
ized by abnormal SEPTIN2 localization and intercellular bridge
instability.
We reasoned that if the ARF6 and Rab35 GTPases act
antagonistically in the same recycling pathway essential for
cytokinesis (Figures 1, S1A, 2A, and S2A), either ARF6-GTP
(ARF6 Q67L) acts upstream and induces the conversion of
Rab35 to its GDP-bound inactive state (model 1, Figure S2B),
or Rab35-GDP (Rab35 S22N) acts upstream and induces the
conversion of ARF6 to its GTP-bound active state (model 2,
Figure S2B). In agreement with the first scenario, we found
that cytokinesis defects observed after ARF6 Q67L overex-
pression were reduced approximately 2-fold by the coexpres-
sion of a constitutively GTP-bound (GTPase-deficient) mutant
of Rab35 (Rab35 Q67L) (Figures 2A and 2B). Rab35 Q67L
overexpression alone, which does not inhibit endocytic
recycling [12], did not perturb cytokinesis either (Figures 2A
and 2B). Furthermore, cytokinesis defects induced by Rab35
S22N overexpression were not suppressed by coexpression
of a GDP-bound dominant-negative ARF6 mutant (ARF6
T27N, Figure S2C), in contradiction with model 2. Further
supporting model 1, and consistent with cytokinesis defects
being associated with endocytic defects after ARF6 Q67L
overexpression, the number of cells displaying intracellularvacuoles was also reduced after coexpression of the constitu-
tively active Rab35 Q67L mutant (Figure 2C). Importantly,
these epistasis experiments were confirmed by directly
measuring the levels of activated Rab35, using a recently
developed GTP-Rab35 trap [24]. Indeed, we observed that
GTP-bound Rab35 levels were strongly reduced in cells that
expressed ARF6 Q67L (Figure 2D). Altogether, we conclude
that ARF6 acts upstream of Rab35 in the same endocytic recy-
cling pathway important for cytokinesis, and that GTP-bound
active ARF6 promotes the conversion of Rab35 into its inac-
tive, GDP-bound state.
EPI64B Is a Rab35 GAP in Both Endocytic Recycling
and Cytokinesis
To explore the molecular mechanism implicated in this ARF/
Rab cascade, we focused our attention on the members of
the EPI64/TBC1D10 protein family (Figure S3A). Indeed,
EPI64A, EPI64B, and the immune-specific EPI64C have been
shown to display a GAP activity toward the Rab35 GTPase,
with Rab35 appearing as the preferred substrate for EPI64B
in systematic analysis in vitro [25, 26]. In addition, EPI64C
overexpression reduces GTP-bound Rab35 levels in vivo [24].
Interestingly, the overexpression of EPI64A leads to the
accumulation of intracellular, F-actin-positive membranes of
unknown origin [27], which resemble the F-actin-positive
intracellular vacuoles described in Figure S1A. We focused
on EPI64B because RT-PCR revealed that EPI64B was the
major EPI64 family member expressed in HeLa cells (data not
shown).
To test whether EPI64B is a functional Rab35 GAP able to
control the Rab35 endocytic pathway and cytokinesis, we first
analyzed whether overexpression of the GDP-bound Rab35
S22N mutant and overexpression of EPI64B led to identical
endocytic recycling defects. EPI64B overexpression induced
Figure 2. ARF6 Acts Upstream of Rab35 and
Antagonizes Rab35 Activation during Both Inter-
phase and Cytokinesis
(A) Dividing HeLa cells expressing the Rab35
S22N mutant or the ARF6 Q67L mutant or the
Rab35 Q67L mutant, or coexpressing Rab35
Q67L and ARF6 Q67L were stained for SEPTIN2
(green) when the intercellular bridge was present
(labeledbyacetyl [ac]-tubulin, red). Blue indicates
DAPI staining. Note that SEPTIN2 is strongly
delocalized from the bridge region (brackets) to
intracellular membranes (arrowheads) in cells
expressing the Rab35 S22N mutant or the ARF6
Q67L mutant. Scale bars represent 10 mm.
(B) Number of binucleated cells after transfection
with control (empty) plasmid, GTPase-deficient
Rab35 Q67L-encoding plasmid, or ARF6 Q67L-
encoding plasmid, or after cotransfection with
ARF6Q67L- andRab35Q67L-encoding plasmids
for 48 hr, mean 6 SEM for five independent ex-
periments, 250–450 cells per experiment. ***p <
8 3 1023 (Student’s t test); NS, not significant.
(C) Number of HeLa cells with SEPTIN2-positive
intracellular vacuoles after cotransfection either
with control (empty) and ARF6 Q67L-encoding
plasmids or with ARF6 Q67L- and Rab35 Q67L-
encoding plasmids, as indicated. **p = 4 3 1022
(Student’s t test), mean6 SEM for three indepen-
dent experiments, 100–150 cells analyzed per
experiment.
(D) COS7 cells were cotransfected with wild-type Flag-Rab35 and either control or ARF6 Q67L-encoding plasmids for 48 hr. The upper panel indicates the
amount of GTP-bound Flag-Rab35 that has been selectively pulled down from each cell lysate (see Supplemental Experimental Procedures). The amount of
total (GDP- and GTP-bound) Flag-Rab35 (1% input) in each lysate is presented in the lower panel.
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149the formation of intracellular vacuoles positive for F-actin,
PI(4,5)P2, SEPTIN2, MHC-I, and TfR, as well as a strong reduc-
tion of SEPTIN2 at the cell cortex (Figure S3B), as observed in
Rab35-GDP mutant-expressing cells (Figures 1A and S1A).
These vacuoles were not marked by the Rab4, Rab5, or
Rab11 endocytic markers (Figure S3C). Consistent with endo-
cytosis being perturbed, overexpression of EPI64B strongly
inhibited the fast recycling of TfR from endosomes to the
plasma membrane (Figure S3D), as observed in Rab35
S22N-expressing cells (Figure 1B). Of note, the formation of
intracellular vacuoles was dependent on the GAP activity of
EPI64B (data not shown). In addition, the presence of intracel-
lular vacuoles in EPI64B-expressing cells was suppressed by
the coexpression of the constitutively active, GTP-bound
Rab35 Q67L mutant (Figure 3A). Finally, GTP-bound Rab35
levels were strongly reduced in cells expressing EPI64B, but
not the GAP-defective mutant EPI64B R409K (Figure 3B),
demonstrating that Rab35 was indeed inactivated in EPI64B-
expressing cells.
We next analyzed whether the overexpression of EPI64B
perturbed cytokinesis. Time-lapse microscopy further sup-
ported the role of EPI64B as a Rab35 GAP: cytokinesis failed
after furrow ingression in 16% (n = 224) of the EPI64B-express-
ing cells (Figure S3E), andwas associatedwith a delocalization
of SEPTIN2 from the bridge to intracellular membranes (Fig-
ure 3C). In addition, cytokinesis failures depended on the
GAP activity of EPI64B, because no cytokinesis defects were
observed upon overexpression of the catalytically defective
mutant EPI64BR409K (Figure 3D). Importantly, the cytokinesis
defects (Figures 3C and 3D) in EPI64B-expressing cells were
suppressed by the coexpression of the constitutively active,
GTP-bound Rab35 Q67L mutant, confirming that Rab35 is
the relevant target of EPI64B in vivo.To further support that EPI64B is a Rab35 GAP, we analyzed
whether these two proteins colocalized during endocytosis in
interphase and during cytokinesis.We first investigated Rab35
and EPI64B localization in interphase cells, because cytoki-
nesis defects are likely a consequence of interphase endocytic
defects. Indeed, abnormal endocytic recycling in interphase
led to the formation of intracellular vacuoles (Figures 1A and
S3B) that were still present and positive for SEPTIN2 during
mitosis (arrowheads, Figures 2A and 3C). In addition, time-
lapse microscopy indicated that cells containing vacuoles
prior to mitosis displayed cytokinesis defects (data not
shown). Altogether, this is consistent with cytokinesis defects
being a consequence of the delocalization of SEPTIN2 from
the cell cortex to intracellular membranes before cell division
in Rab35 S22N-, EPI64B-, and ARF6 Q67L-expressing cells.
Using immunoelectron microscopy, we reported that Rab35
is localized at the plasma membrane and in clathrin-coated
pits, as well as in internal endosomes in interphase [12]. This
has been confirmed in fixed cells using immunocytochemistry
in mammalian cells and C. elegans [28, 29], but the fraction
of clathrin-coated pits loaded with Rab35 and the dynamics
of Rab35 in these structures were unknown. In addition,
EPI64 family members have been described at the plasma
membrane, but no detailed localization has been reported
[25–27]. Using total internal reflection fluorescence (TIRF)
microscopy on living HeLa cells coexpressing wild-type
GFP-Rab35 and dsRed-clathrin light chain (CLC), Rab35 was
found to colocalize with CLC-positive spots at the plasma
membrane, corresponding to either clathrin-coated pits or
clathrin-coated platforms from which vesicles bud (Figure 3E).
Only a fraction of CLC-positive spots (8.4% 6 0.6%, mean 6
SEM, 7,744 CLC-positive spots analyzed) was labeled by
Rab35 during the recording of 1 min movies, with Rab35
Figure 3. EPI64B Is a Rab35 GAP during Interphase and Cytokinesis and Transiently Colocalizes with Rab35 at the Plasma Membrane in Clathrin-Coated
Structures
(A) Number of HeLa cells with SEPTIN2-positive intracellular vacuoles after cotransfection either with control (empty) and EPI64B-encoding plasmids, or
with EPI64B- and Rab35 Q67L-encoding plasmids, as indicated. ***p = 1.6 3 1023 (Student’s t test), mean 6 SEM for three independent experiments,
50–150 cells analyzed per experiment.
(B) The amount of GTP-bound Flag-tagged Rab35 in cell lysates expressing control (empty), EPI64B-, or GAP-deficient EPI64B R409K-encoding plasmids
was analyzed as in Figure 2D.
(C) SEPTIN2 localization (green) in dividing cells transfected with control (empty) or EPI64B-encoding plasmids, or cotransfected with EPI64B and Rab35
Q67L-encoding plasmids (see also Figure 2A). Scale bars represent 10 mm.
(D) Number of binucleated cells after transfection with control (empty) plasmid, EPI64B- or GAP-deficient R409K EPI64B mutant-encoding plasmids, or
Rab35 Q67L-encoding plasmid, or after cotransfection with EPI64B- and Rab35 Q67L-encoding plasmids for 48 hr, mean 6 SEM for four independent
experiments, 300–400 cells per experiment. ***p = 5 3 1023 (Student’s t test); NS, not significant.
(E) HeLa cells cotransfected with GFP-tagged wild-type Rab35 (displayed in green) and dsRedFP-tagged CLC (displayed in red) were recorded by time-
lapse TIRF microscopy. Upper panel shows a temporal projection of a representative 1 min movie. Inset shows the indicated regions (dashed line) at higher
magnification. Scale bar represents 10 mm. Lower panel shows quantification of Rab35/CLC colocalization in 1 min movies (n = 7,744 clathrin-coated spots
analyzed).
(F) HeLa cells cotransfected with cherryFP-tagged EPI64B (displayed in green) and GFP-tagged CLC (displayed in red) were analyzed and quantified as
described in (E) (n = 2,228 clathrin-coated spots analyzed). Scale bar represents 10 mm.
(G) HeLa cells were cotransfected with GFP-tagged wild-type Rab35 (green) and cherryFP-tagged EPI64B (red). Snapshots of representative time-lapse
TIRF microscopy image series are displayed. Either EPI64B spots appear and disappear without Rab35 labeling (upper panels, 85% of the cases) or
Rab35 appears when EPI64B staining decreases (lower panels, 15% of cases; n = 680 EPI64B spots analyzed).
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3.5% (2,228 CLC-positive spots analyzed) of the CLC-positive
spots became positive for EPI64B during the recording of
1 min movies (Figure 3F). When we examined the relative
dynamics of EPI64B and Rab35, the majority of EPI64B
spots appeared and disappeared without any Rab35 labeling
(85%6 1.8%, 680 EPI64B-positive spots analyzed; Figure 3G,
upper panel). Strikingly, in 15% of EPI64B spots, Rab35
appeared and accumulated only when EPI64B decreased
from a given spot at the plasma membrane (Figure 3G, lower
panel). Importantly, we never observed a Rab35 spot that later
became positive for EPI64B. These observations indicate that
EPI64B and Rab35 transiently colocalize in CLC-positive
structures at the plasma membrane. In addition it stronglysuggests that EPI64B controls Rab35 association to CLC-
positive structures by limiting Rab35 activation at early steps
of endocytosis (see also below). Of note, the dynamics and
localization of Rab35 and EPI64B in CLC-positive structures
at the plasma membrane were confirmed in cells during cyto-
kinesis (Figure S3F). Altogether, we conclude that EPI64B is
a functional RabGAP that specifically converts Rab35 into its
GDP state, and that there is a tight temporal control of
EPI64B/Rab35 localization in CLC-positive structures.
GTP-Bound ARF6 Interacts with EPI64B and Negatively
Regulates Rab35 Activation in Clathrin-Coated Structures
Because we identified EPI64B as the relevant RabGAP for
Rab35 in both endocytic recycling and cytokinesis, we next
Figure 4. GTP-Bound ARF6 Interacts Directly with EPI64B and Negatively Regulates Rab35 Activation in Clathrin-Coated Structures
(A) Binding of recombinant hexahistidine-tagged EPI64B (aa 1–650) to indicated recombinant GST, GST-ARF6 Q67L, GST-ARF6 T44N, or GST-ARF1 Q71L
(mean 6 SEM, n = 3 experiments).
(B) HeLa cells were cotransfected with cherryFP-EPI64B (displayed in green) and GFP-tagged wild-type ARF6 (displayed in red). Temporal projection and
snapshots of a representative 1 min time-lapse TIRF microscopy movie are displayed. Scale bar represents 10 mm.
(C) HeLa cells treated with either control or two independent ARF6 siRNAs for 3 days were then cotransfected with cherryFP-tagged EPI64B and GFP-
tagged CLC for 24 hr. Cells were recorded by time-lapse TIRF microscopy for 1 min movies. The percentage of CLC-positive spots that were positive
for EPI64B is displayed for each analyzed cell (diamonds). Median (red cross) and mean (red bar) of the distribution are indicated. A total of 2,700–5,000
clathrin-coated structures were analyzed. ***p < 4 3 1025 (Student’s t test).
(D) HeLa cells expressing both GFP-tagged wild-type Rab35 and dsRedFP-CLC were cotransfected with either control, EPI64B-, or ARF6 Q67L-encoding
plasmids. Cells were recorded by time-lapse TIRF microscopy, and quantification of Rab35/CLC colocalization in 1 min movies in each condition is dis-
played (n > 5,000 clathrin-coated structures analyzed per condition). ***p < 9 3 1023 (Student’s t test).
(E) HeLa cells treated with either control or two independent EPI64B siRNAs for 2 days were then transfected with control (empty) or with the HA-tagged
ARF6 Q67L mutant-encoding plasmid. The number of HA-positive, binucleated cells was quantified 48 hr after the plasmid transfection (mean6 SEM, n = 3
independent experiments, 400 cells per experiment). ***p < 3 3 1023 (Student’s t test).
(F) Binding of recombinant hexahistidine-tagged EPI64B (aa 1–650) to recombinant untagged Rab35 Q67L (as in A) (black bars), in the presence of
GST-tagged ARF6 Q67L or GST-tagged ARF1 Q71L. Rab6 Q72L was used as a negative control (gray bars) (mean 6 SEM, n = 4 experiments). ***p =
3.4 3 1023 (Student’s t test).
(G) Proposed molecular model for the ARF6/Rab35 cascade regulating Rab35 activation in endocytosis and cytokinesis.
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we describe. So far, EPI64A has been shown to interact with
the GTP-bound form of the ARF6 GTPase [27], which raises
the possibility that other members of this family could also
bind to activated ARF6. This would provide a molecular mech-
anism explaining how ARF6-GTP inhibits Rab35 activation.
Two-hybrid experiments indicated that full-length EPI64Binteracted with the GTP-bound (ARF6 Q67L) but not with the
GDP-bound (ARF6 T27N) mutant of ARF6 (data not shown).
In addition, recombinant EPI64B (aa 1–650) was able to bind
in a dose-dependent manner with purified ARF6 Q67L, but
not ARF6 T44N or ARF1 Q71L (Figure 4A). This demonstrates
that EPI64B directly interacts with GTP-bound ARF6. Consis-
tent with this interaction, ARF6 and EPI64B colocalized in
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copy analysis revealed that 98.9% 6 0.8% of the ARF6-
positive spots were positive for CLC (1,484 clathrin-positive
structures analyzed), an observation that was also recently
reported in HeLa cells and BSC-1 cells [30]. Of note, we
observed that wild-type ARF6 and ARF6 Q67L always
preceded EPI64B appearance at CLC-positive spots, suggest-
ing that ARF6 could recruit EPI64 in these structures (Figures
4B and S4A). Consistent with this hypothesis, the number of
CLC-positive spots that were EPI64B-positive was reduced
after ARF6 depletion by RNAi, a result that was confirmed
with two independent siRNAs (3,500–4,000 clathrin spots
analyzed; Figures 4C and S4B). In addition, colocalization
between ARF6 and EPI64B was also observed during cytoki-
nesis (Figure S4C). Thus, GTP-bound ARF6 interacts with
EPI64B, and ARF6 is important for the proper localization of
EPI64B in CLC-positive structures.
Because both EPI64B and ARF6 partially overlapwith Rab35
(Figures 3G, S3F, S4D, and S4E), we next investigated whether
the overexpression of the GTP-bound ARF6 mutant or the
overexpression of EPI64B could perturb Rab35 association
to CLC-positive structures. Indeed, contrary to theGTP-bound
Rab35 Q67L mutant, the GDP-bound Rab35 S22Nmutant was
not detected in CLC-positive structures (data not shown), sug-
gesting that only activated Rab35 could enter the clathrin-
dependent endocytic pathway. TIRF microscopy revealed
that the mean number of CLC-positive spots in which Rab35
was loaded was reduced after either EPI64B or ARF6 Q67L
overexpression (5,000–8,000 clathrin spots analyzed; Fig-
ure 4D). This is consistent with EPI64B being a functional
Rab35 GAP that controls Rab35 activation in CLC-positive
structures, and with the epistasis experiments placing ARF6
upstream of Rab35 and inhibiting Rab35 activation (Figure 2).
To test the contribution of EPI64B in this ARF6/Rab35
cascade, we next analyzed whether the endocytic and cytoki-
nesis defects associated with ARF6 overactivation were
reduced in EPI64B-depleted cells, using two independent
siRNAs (Figure S4F). Following EPI64B depletion, the number
of cells with vacuoles (Figure S4G) and the cytokinesis failures
induced by the overexpression of ARF6 Q67L were indeed
reduced (Figure 4E). These results indicate that the endocytic
and the cytokinesis defects resulting from the overactivation
of the ARF6 pathway are, at least in part, dependent on the
presence of the Rab35 GAP EPI64B. Interestingly, we found
that EPI64B binds to Rab35 in a dose-dependent manner (Fig-
ure S4H), and that this interaction was increased by >40% in
the presence of GTP-bound ARF6 (Figure 4F). This suggests
that the presence of GTP-bound ARF6 at CLC structures
favors both EPI64B recruitment and the interaction with its
target Rab35. Altogether, we conclude that EPI64B functions
downstream of ARF6-GTP and that EPI64B is an ARF6 effector
that regulates Rab35 activation.
In this report, we describe an original cascade of two
GTPases from different families that control the activation
of a common recycling pathway required for successful cyto-
kinesis. We found that ARF6 acts upstream of Rab35 and
that ARF6-GTP negatively regulates the activation of Rab35
through the Rab35 GAP EPI64B (Figure 4G). We propose that
the overactivation of the ARF6 GTPase inhibits loading of
Rab35 in the endocytic pathway. As a consequence, this per-
turbs endocytic recycling, delocalizes SEPTIN2 cytoskeleton
elements from the cell cortex to intracellular vacuoles, and
hence induces cytokinesis failure. Thus, ARF6 activation
must be precisely regulated for successful cytokinesis,because ARF6 overactivation leads to intercellular bridge
instability whereas ARF6 inactivation leads to later penetrant
abscission defects [14, 15]. Overactivation of ARF6 has been
reported to inhibit several other key cellular functions (such
as cell migration, Ca2+-dependent exocytosis, tumor growth)
and to promote cancer metastasis and invasiveness, through
various effectors and pathways [17]. In light of the present
results, it should thus be important to reconsider whether
those defects could be, at least in part, attributed to the inhibi-
tion of the Rab35-recycling pathway itself. Finally, this anta-
gonistic ARF/Rab cascade may represent a general mecha-
nism for regulating the sequential activation of Rab GTPases
in a transport pathway. Indeed, the notion of ‘‘Rab cascade’’
recently emerged, whereby successive Rab GTPases recruit
the GEFs and GAPs of other GTPases belonging to the same
pathway [19, 20, 31–33]. In particular, in a transport step
between two successive compartments, a Rab GTPase on
the second compartment terminates the activation of a Rab
GTPase characteristic of the first compartment by recruiting
the corresponding RabGAP [33]. Here, we propose a comple-
mentary and reciprocal mechanism of regulation: a GTPase of
the first compartment (in this case an ARF GTPase) prevents
the precocious activation of the second Rab GTPase by re-
cruiting the corresponding RabGAP. This mutual inhibition,
based on RabGAPs, constitutes a switch, which ensures
that each GTPase is active on a particular compartment. Inter-
estingly, it has been reported that GTP-bound Rab35 also
interacts with an ARF6 GAP [34] that would be an exact
counterpart of the cascade described here. In addition, our
results indicate that Rab35 loading into the endocytic pathway
depends on a balance between Rab35 GAP and Rab35 GEF,
because overexpression of Rab35 S22N (which acts as a
dominant negative by sequestrating Rab35 GEFs) inhibited
wild-type Rab35 localization in CLC-positive structures
(data not shown). Thus, recruitment or activation of a specific
Rab35 GEF at CLC-positive structures would contribute to flip
the switch and to promote vectorial transport in a trafficking
pathway.
Supplemental Information
Supplemental Information includes four figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.
1016/j.cub.2011.11.058.
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